glucomannan
Botanicalexperimental
Glucomannan is a water-soluble polysaccharide that is considered a dietary fiber. It is a hemicellulose component in the cell walls of some plant species. Glucomannan is a food additive used as an emulsifier and thickener. It is a major source of mannan oligosaccharide (MOS) found in nature, the other being galactomannan, which is insoluble. — Wikipedia
Clinical trial activity
14 trials · 13 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
1
Phase 4
4
Earliest trial started Jan 31, 1991 (NCT03741686)
Timeline
Indications
Approved for
Studied for
- Constipation · Phase 3
- Coronary Disease · Phase 2
- Diabetes Mellitus, Type 2 · Phase 2
- Gastrointestinal Diseases · Phase 4
- Hypoglycemia · Phase 4
- Insulin Resistance · Phase 2
- Metabolic Syndrome · Phase 2
- Non-alcoholic Fatty Liver Disease · Phase 2
- Obesity · Phase 4
- Overweight · Phase 4
- Self Efficacy · Phase 4
- Weight Loss · Phase 4
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGlucomannan ↗
Also known as
- (1-6)-alpha-d-gluco-d-mannan
- (1-6)-alpha-glucomannan
- alpha-d-gluco-d-mannan, (1-6)-
- glucomanna
- glucomannan
- glucomannan
- glucomannan
- konjac glucomannan
- konjac gluco-mannan
- konjac mannan
- manna
- manna
- manna
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05850949 | N/A | May 10, 2023 | Universitas Katolik Widya Mandala Surabaya |
| NCT04250831 | N/A | Mar 12, 2018 | Roehampton University, University of Roehampton |
| NCT03557424 | Phase 4 | Apr 26, 2017 | Heilpflanzenwohl AG |
| NCT02280772 | Early Phase 1 (Phase 1) | Apr 1, 2015 | Medical University of Warsaw |
| NCT02134938 | Phase 1 | Jul 31, 2013 | Unity Health Toronto, University of Toronto |
| NCT02336438 | Phase 4 | May 1, 2013 | Bassett Healthcare |
| NCT01485718 | Phase 4 | Oct 1, 2011 | ProMedica Health System |
| NCT01553500 | Phase 2 | Jun 1, 2011 | Bambino Gesù Hospital and Research Institute |
| NCT01709955 | Phase 1 | Feb 1, 2011 | New York Chiropractic College |
| NCT01495806 | Phase 4 | Jan 1, 2010 | Medical University of Warsaw |
| NCT01151878 | Phase 3 | Apr 1, 2009 | Medical University of Warsaw |
| NCT00465036 | N/A | Oct 1, 2006 | University of Copenhagen |
| NCT03741686 | Phase 2 | Jan 31, 1991 | Dicofarm, University of Toronto |
| NCT03741660 | Phase 2 | Jan 31, 1991 | Dicofarm, University of Toronto |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical University of Warsaw | Academic/Hospital | 3 | 3 | 3 | 2009 |
| University of Toronto | Academic/Hospital | 3 | 2 | 2 | 1991 |
| Dicofarm | For profit | 2 | 0 | 1 | 1991 |
| Bambino Gesù Hospital and Research Institute | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Bassett Healthcare | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Heilpflanzenwohl AG | For profit | 1 | 1 | 1 | 2017 |
| New York Chiropractic College | Academic/Hospital | 1 | 1 | 1 | 2011 |
| ProMedica Health System | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Roehampton University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Unity Health Toronto | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Universitas Katolik Widya Mandala Surabaya | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2006 |
| University of Roehampton | Academic/Hospital | 1 | 1 | 1 | 2018 |
13 organizations
Page 1 / 1